Investor Relations

Corporate Profile

Helius Medical Technologies is a publicly traded company on the NASDAQ (HSDT) in the United States. Visit the About page to see how our company has developed, or see the PoNS™ page to learn about the science behind our flagship device.

Stock Quote & Chart

Data Provided by Refinitiv. Minimum 15 minutes delayed.

News Releases
April 3, 2024
Helius Medical Technologies, Inc. Announces Partnership with Lovell® Government Services to Expand Reach of PoNS Therapy™
March 28, 2024
Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
March 15, 2024
Helius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024
March 12, 2024
Helius Medical Technologies, Inc. Initiates Open-Label Study for Registrational Program in Stroke
March 7, 2024
Helius Medical Technologies, Inc. to Present at the 36th Annual ROTH Conference
March 4, 2024
Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS®) Mouthpiece and Controller
February 6, 2024
Helius Medical Technologies, Inc. Announces Alignment with FDA on Registrational Program for Treatment of Stroke Patients
February 5, 2024
Helius Booth and Special Event at APTA Combined Sections Meeting Will Highlight Physical Therapists’ Ability to Customize PoNS Therapy® to Improve Gait in People with MS
January 11, 2024
Helius Medical Technologies, Inc. Announces Further Expansion of Stroke Clinical Program with the Addition of Brooks Rehabilitation Hospital

Events

Presentations